CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

938.3M

Vuru Grade

50.85/100

Current Price

$40.16
+1.635 (+4.24%)

Growth Price

$9.16
Overvalued by 77.19%

Stability Price

$14.72
Overvalued by 63.35%

Company Metrics

  • 19.65 P/E
  • 4.43 P/S
  • 4.19 P/B
  • 1.96 EPS
  • 39.91% Cash ROIC
  • 1.32 Cash Ratio
  • 0 / 0% Dividend
  • 20,645.00 Avg. Vol.
  • 26.65M Shares
  • 938.3M Market Cap.

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.